Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Profiling risk and new therapeutic interventions: looking ahead

J Shepherd1

  • 1Department of Pathological Biochemistry, Institute of Biochemistry, Royal Infirmary, University of Glasgow, Scotland, United Kingdom.

The American Journal of Medicine
|April 29, 1998
PubMed
Summary

Lowering cholesterol effectively prevents coronary artery disease (CAD). Atorvastatin offers superior LDL cholesterol and triglyceride reduction compared to other statins, aiding CAD prevention.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Exploring the knowledge base of ChatGPT in lateral elbow tendinopathy.

Shoulder & elbow·2026
Same author

Statistical shape modelling of the first carpometacarpal joint: A cross-sectional analysis of an osteoarthritis initiative cohort.

Bone·2025
Same author

How do digital range of motion measurement devices 'measure-up' to traditional goniometry in assessing shoulder range of motion? A systematic review and meta-analysis.

Shoulder & elbow·2024
Same author

The economic and resource burden of e-scooter-related orthopaedic injuries: A district general hospital's experience.

Injury·2024
Same author

Development of a novel micro-bead force spectroscopy approach to measure the ability of a thermo-active polymer to remove bacteria from a corneal model.

Scientific reports·2021
Same author

Risk factors for preeclampsia and eclampsia at a main referral maternity hospital in Freetown, Sierra Leone: a case-control study.

BMC pregnancy and childbirth·2021

Area of Science:

  • Cardiology
  • Pharmacology

Background:

  • Cholesterol management is crucial for coronary artery disease (CAD) prevention.
  • Accurate CAD risk assessment requires evaluating specific lipid levels (LDL, HDL, triglycerides) and other factors like smoking, weight, family history, age, and hypertension.
  • Absolute risk determination is preferred over relative risk.

Purpose of the Study:

  • To highlight the importance of comprehensive CAD risk assessment beyond total cholesterol.
  • To compare the efficacy of atorvastatin with other statins in lowering LDL cholesterol and triglycerides.

Main Methods:

  • Review of established benefits of cholesterol lowering in CAD prevention.
  • Discussion of factors influencing CAD risk assessment.
  • Comparison of statin efficacy, focusing on atorvastatin's effects on LDL cholesterol and triglycerides.

Related Experiment Videos

Main Results:

  • Low-density lipoprotein (LDL) cholesterol is a potent CAD risk predictor, with triglycerides also being significant.
  • 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors (statins) are first-line therapy for elevated LDL cholesterol.
  • Atorvastatin demonstrates greater efficacy in lowering LDL cholesterol and triglycerides at maximal dosage compared to other statins.

Conclusions:

  • Comprehensive assessment of lipid profiles and risk factors is essential for effective CAD prevention.
  • Atorvastatin represents a significant advancement in statin therapy due to its superior efficacy in managing LDL cholesterol and triglycerides.